Notify Me
Sain Medicaments Pvt Ltd

ENTROQUINE 125 Tablet 20's

Amoebiasis
MRP ₹30.00 (Inclusive of all taxes)
New Reduced MRP as per revised GST benefit.
Deliver to

    Netmeds First Membership

    Starting at just ₹[] for 3 months.
    View Plans

    Introduction About ENTROQUINE 125 TABLET

    ENTROQUINE 125 TABLET contains Quiniodochlor, which belongs to the group of medicines called Antiprotozoals. It is used to manage protozoal infections such as Amoebiasis, Giardiasis and Trichomonas vaginitis in adults.

    Amoebiasis is a parasitic infection of the intestine which causes fever, diarrhoea, blood in the stools, nausea, vomiting, weight loss and stomach cramps and Giardiasis is a parasitic intestinal infection characterised by stomach cramps, bloating, nausea and diarrhea.

    Trichomonas vaginitis is a type of sexually transmitted parasitic infection of the vagina. Symptoms include foul-smelling vaginal discharge, itching and painful urination.

    The risks and benefits of ENTROQUINE 125 TABLET for use in pregnancy and breastfeeding are not known. Inform your doctor if you are pregnant or breastfeeding before taking this medicine.

    ENTROQUINE 125 TABLET is not recommended for use in children as it may cause blindness. Consult your doctor immediately if you experience any unusual side effects while taking this medicine.

    Uses Of ENTROQUINE 125 TABLET

    To manage parasitic infections such as:

    • Amoebiasis
    • Giardiasis
    • Trichomonas vaginitis

    How ENTROQUINE 125 TABLET Works

    ENTROQUINE 125 TABLET works by killing the parasitic-producing infective cyst. As a result, it manages and controls parasitic infections in adults.

    How to use ENTROQUINE 125 TABLET

    Take ENTROQUINE 125 TABLET as advised by your physician. Swallow the medicines with a glass of water. Do not crush or chew the medicine. Your physician will fix the correct dose and frequency for you based upon your age, body weight and disease condition.

    Warning & Precautions

    Pregnancy

    The risks and benefits of ENTROQUINE 125 TABLET for use in pregnant women are not known. Inform your doctor if you are pregnant or planning to have a baby before taking ENTROQUINE 125 TABLET.

    Breastfeeding

    The risks and benefits of ENTROQUINE 125 TABLET for use in breastfeeding mothers are not known. Consult your doctor for advice.

    Allergy

    Do not take ENTROQUINE 125 TABLET if you are allergic to Quiniodochlor or any other ingredients of this medicine.

    Others

    Use in Pediatrics:

    ENTROQUINE 125 TABLET is not recommended for use in children as it may cause blindness. Consult your doctor before taking it.

    Interactions

    A. Drug-Drug interactions:

    Before taking ENTROQUINE 125 TABLET, inform your doctor if you are taking, have taken or might take any other medicine, including prescription, non-prescription or any herbal medicine.

    Overdosage:

    If you or anyone else accidentally took too much of ENTROQUINE 125 TABLET, consult your doctor immediately or visit the nearby hospital.

    Synopsis

    Drug :   Quiniodochlor
    Pharmacological Category :   Antiprotozoals
    Therapeutic Indication :   Amoebiasis, Giardiasis and Trichomonas vaginitis
    Dosage Forms :   Tablet

    More Information

    • Keep ENTROQUINE 125 TABLET out of reach of children
    • Store ENTROQUINE 125 TABLET at room temperature

    FAQs About ENTROQUINE 125 TABLET

    Q: Can ENTROQUINE 125 TABLET be used for loose motion?

    A: ENTROQUINE 125 TABLET is a prescription medicine used in the management of diarrhoea associated with protozoal infection such as Amoebiasis, Giardiasis and Trichomonas vaginitis.

    Q: Is ENTROQUINE 125 TABLET effective?

    A: ENTROQUINE 125 TABLET is proven effective when taken as advised by your doctor. It works by destroying the parasitic-producing infective cyst which helps in controlling parasitic infections in adults.

    Q: How long should I take ENTROQUINE 125 TABLET?

    A: Take ENTROQUINE 125 TABLET as advised by your doctor. The usual duration of management is at least 14 days unless otherwise directed by your doctor. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.

    Q: Does ENTROQUINE 125 TABLET cause peripheral neuritis?

    A: Relatively prolonged and uninterrupted management with ENTROQUINE 125 TABLET used in high dosage for more than fourteen days have been reported to cause peripheral neuritis and damage to the optic nerves in isolated cases.

    Q: Are there any contraindicated conditions associated with ENTROQUINE 125 TABLET?

    A: Do not take ENTROQUINE 125 TABLET if you are allergic to Quiniodochlor. Inform your doctor about all the medicine that you currently take. studies have shown that, ENTROQUINE 125 TABLET causes potential reactions in patients suffering from asthma. Therefore, consult your doctor before taking.

    Q: What is ENTROQUINE 125 TABLET used for?

    A: Adults with protozoal illnesses such as Amoebiasis, Giardiasis and Trichomonas vaginitis can be managed with ENTROQUINE 125 TABLET. Amoebiasis is a parasitic infection of the intestine which causes fever, diarrhoea, blood in the stools, nausea, vomiting, weight loss and stomach cramps. Giardiasis is a parasitic intestinal infection characterised by stomach cramps, bloating, nausea and diarrhea and Trichomonas vaginitis is a type of sexually transmitted parasitic infection of the vagina and its symptoms include foul-smelling vaginal discharge, itching and painful urination. Contact your doctor before taking it.

    Q: How often can I use ENTROQUINE 125 TABLET?

     A: Take ENTROQUINE 125 TABLET as advised by your doctor. It should be taken thrice daily or as directed by the physician. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.

    Q. Is ENTROQUINE 125 TABLET safe?

    ENTROQUINE 125 TABLET is considered safe when taken according to the prescribed dose and duration under your doctor's guidance. Adhere to the instructions precisely, without skipping any doses. Follow your doctor's guidance closely, and inform them if you experience any bothersome side effect

    Q. What if I forget to take a dose of ENTROQUINE 125 TABLET?

    If you miss a dose of ENTROQUINE 125 TABLET, take it as soon as you recall. Nonetheless, if your next scheduled dose is approaching, skip the missed dose, and adhere to the regular dosing schedule. Avoid doubling the dose to compensate for the missed one, as this may elevate the risk of experiencing side effects.

    Q: Is ENTROQUINE 125 TABLET safe for use in pregnant women?

    A: The associated risks and benefits of ENTROQUINE 125 TABLET for use during pregnancy are not known. Inform your doctor if you are planning or planning to have a baby before taking ENTROQUINE 125 TABLET.

    References

    1. KD. Tripathi. Antimicrobial drugs. Essentials of medical pharmacology. 8th Edition. 2019. Page – 898.

    2. Prachayasittikul V, Prachayasittikul S, Ruchirawat S, Prachayasittikul V. 8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications. NIH National Library of Medicine, National Center for Biotechnology Information. PubMed Central. October 2013. [Accessed on 18th July 2022]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793592/

    3. Gera Parul, S.K. Sharma, Bhudiraja Rajat. Colon Targeting Drug - Synthesis and evaluation of prodrugs of Quiniodochlor by -Glucosidase enzyme with HPLC methodology. International Journal of Drug Development and Research. March 2012. [Accessed on 18th July 2022]. https://www.researchgate.net/publication/288132239_

    4. Entero Quinol (Quiniodochlor 250mg). East India Pharmaceutical Works Limited. [Accessed on 18th July 2022]. https://eastindiapharma.org/therapies/antiprotozoal/entero-quinol/

    Useful Diagnostic Tests

    • CBC
    • Blood smear test
    • Stool examination test
    • Liver function test

    Author Details

    Written By Srilekha. R - B.Pharm
    Reviewed For Accuracy By Dr. Nitin Sattiwale - MBBS
    Last updated on 09 Feb 2024 | 06:39 PM(IST)
    Lab updated